Annual Drug Patent Expirations for SYMBICORT
Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for SYMBICORT.
The generic ingredient in SYMBICORT is budesonide; formoterol fumarate dihydrate. Three suppliers are listed for this compound. Additional details are available on the budesonide; formoterol fumarate dihydrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
